9 insiders reported 26 Form 4 transactions for Tevogen Bio Holdings Inc. (TVGN) over the past 18 months (most recent 2026-09-16). Recent activity: Saadi Ryan H. (Chief Executive Officer) Buy 8.0M shares, Desai Kirti (Chief Financial Officer) Buy 750,000 shares, PODLOGAR SUSAN M (Director) Buy 75,000 shares, Sordillo Victor J. (Director) Buy 75,000 shares, Patton Curtis L. (Director) Buy 75,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Saadi Ryan H. | Chief Executive Officer | Buy | 8.0M | $0 |
| 2026-09-16 | Desai Kirti | Chief Financial Officer | Buy | 750,000 | $0 |
| 2026-09-15 | PODLOGAR SUSAN M | Director | Buy | 75,000 | $0 |
| 2026-09-15 | Sordillo Victor J. | Director | Buy | 75,000 | $0 |
| 2026-09-15 | Patton Curtis L. | Director | Buy | 75,000 | $0 |
| 2026-09-15 | Goh Keow Lin | Director | Buy | 75,000 | $0 |
| 2026-09-15 | Feike Jeffrey L. | Director | Buy | 75,000 | $0 |
| 2026-07-10 | Desai Kirti | Chief Financial Officer | Buy | 40,000 | $0 |
| 2026-07-10 | Saadi Ryan H. | Chief Executive Officer | Buy | 1.2M | $0 |
| 2026-07-10 | Sordillo Victor J. | Director | Buy | 40,000 | $0 |
| 2026-07-10 | Patton Curtis L. | Director | Buy | 40,000 | $0 |
| 2026-07-10 | Goh Keow Lin | Director | Buy | 40,000 | $0 |
| 2026-07-10 | PODLOGAR SUSAN M | Director | Buy | 40,000 | $0 |
| 2026-07-10 | Feike Jeffrey L. | Director | Buy | 40,000 | $0 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 19 | $147 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 452 | $3,282 |
| 2026-03-17 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead. All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026 | Sell | 501 | $3,206 |
| 2025-12-22 | Saadi Ryan H. | Chief Executive Officer | Sell | 50,000 | $0 |
| 2025-12-15 | Desai Kirti | Chief Financial Officer | Sell | 300,000 | $0 |
| 2025-12-12 | Saadi Ryan H. | Chief Executive Officer | Sell | 460,000 | $0 |
| 2025-08-18 | Saadi Ryan H. | Chief Executive Officer | Sell | 20,000 | $0 |
| 2025-07-01 | Khan Sadiq | Chief Commercial Officer | Buy | 200,000 | $0 |
| 2025-07-01 | Saadi Ryan H. | Chief Executive Officer | Buy | 8.0M | $0 |
| 2025-07-01 | Desai Kirti | Chief Financial Officer | Buy | 750,000 | $0 |
| 2025-07-01 | Flomenberg Neal | Chief Scientific Officer, Global R&D Lead | Buy | 300,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16